ASSESSMENT AND EVALUATION OF PATIENT REPORTED OUTCOME IN CABG PATIENTS WITH THE HELP OF CROQ-H IN A TERTIARY CARE HOSPITAL

Authors

  • Madhaw Dwivedi , Sanjay Gandhi , Kalpesh Gaur , Pooja Gandhi

DOI:

https://doi.org/10.47750/pnr.2022.13.S10.088

Abstract

Coronary artery bypass grafting (CABG) is a major surgical procedure where blockages in a patient’s coronary arteries are bypassed with the help of harvested venous or arterial conduits. The bypass graft reestablishes blood flow to the ischemic area of heart which, restores cardiac muscle function, viability, and relieves symptoms of chest pain of angina. Almost 400,000 CABG surgeries are performed each year making it the most commonly performed major surgical procedure.1 Status of health and health-related quality of life (HRQOL) assessed by patient-reported outcome measures (PROMs) directly collect data from the patients’ perspective.2 General health status is computed and reported in terms of mortality and morbidity while PROMs, have the potential to add important information beyond that captured by mortality and morbidity.3 PROMs are used not only to measure health outcomes in research and scrutiny but also to compare the performance of healthcare providers.4

Downloads

Published

2022-12-31 — Updated on 2022-12-31

Issue

Section

Articles

How to Cite

ASSESSMENT AND EVALUATION OF PATIENT REPORTED OUTCOME IN CABG PATIENTS WITH THE HELP OF CROQ-H IN A TERTIARY CARE HOSPITAL. (2022). Journal of Pharmaceutical Negative Results, 825-835. https://doi.org/10.47750/pnr.2022.13.S10.088